Home Blood Pressure Monitoring Before and After COVID-19 Vaccination in Patients at High Risk of Cardiovascular Disease

NCT05033613 | Unknown

• 1 other identifier: 202107076RINA
• Study Type: observational
• Target: 1,500
• Locations: 1 country
• Sites: 1

Brief Summary

The coronavirus SARS-CoV-2 causing COVID-19 was pandemic since 2020. Vaccination is one of the most important measure to control the outbreak. The countries of the world started the vaccination since December, 2020. Taiwan started since March, 21st, 2021. Currently, Taiwanese people receive COVID-19 vaccination by either AZ or Moderna; Pfizer/BNT vaccine may import in the near future. The side effects post vaccination including injection site pain, fatigue, headache, myalgia, chills, arthralgia, fever, and so on. Incidence of side effects more frequent in young people than elders; more frequent in the first dose than second dose in AZ vaccine; more frequent in the second dose in Moderna or Pfizer/BNT vaccine. Taiwan V-watch is a system monitored by CDC for people proactive notification of side effects post COVID-19 vaccination. But it doesn't include the objective cardiovascular parameters, for example, heart rate, arrhythmia, blood pressure, central body temperature (ear temperature) and blood oxygen saturation level. This study aims to monitor the physiologic and psychologic effects, and side effects before and after COVID-19 vaccination in patients at high cardiovascular risk, including hypertension, hyperlipidemia, and type 2 diabetes, and arrhythmia or coronary artery disease. The investigators arrange two weeks of continuous home BP/HR monitoring (7 days pre- and post-vaccination) for evaluation of physiologic effects post vaccination. Due to fever noted in some people post-vaccination, the investigators also measure ear temperature, pulse oximetry, and environmental temperature and humidity, for the reference of BP monitoring. In conclusion, this study may provide important information of cardiovascular response and psychosocial effects after SARS-CoV-2 vaccination for proactive prevention of cardiovascular complications.

Conditions

Pain; Fatigue; Headache; Myalgia; Chills; Arthralgia; Fever

Keywords

COVID-19 vaccination, Side effects

Outcome Measures

Primary Outcomes (3)

• Compare the physiological effects of different type of COVID-19 vaccines

  Compare the physiological effects of different type of COVID-19 vaccines, including cardiovascular aspects, blood pressure, heartbeat, blood oxygen, whether there is arrhythmia, whether there are changes in blood oxygen concentration and core body temperature (ear temperature).

  From 1 Sep. 2021 to 1 Dec. 2022

• Compare whether the subjective side effects of different type of COVID-19 vaccines are different

  Compare whether the subjective side effects of different type of COVID-19 vaccines are different, including fever, headache, dizziness, drowsiness, insomnia, palpitations, arrhythmia, nausea, vomiting, tiredness, pain, redness, heat or swelling at the injection site, difficulty breathing, muscles soreness, muscle weakness, abdominal pain, diarrhea, etc.

  From 1 Sep. 2021 to 1 Dec. 2022

• Compare the psychological stress effects of different type of COVID-19 vaccines

  Compare the psychological stress effects of different type of COVID-19 vaccines, choose to use the CES-D (The Center for Epidemiologic Studies Depression Scale) Questionnaire and PSQI (The Pittsburgh Sleep Quality Index), to measure and check whether there are differences.

  From 1 Sep. 2021 to 1 Dec. 2022

Interventions

heart rate、arrhythmia、blood pressure、central body temperature (ear temperature) and blood oxygen saturation level. OTHER

heart rate、arrhythmia、blood pressure、central body temperature (ear temperature) and blood oxygen saturation level.

Eligibility Criteria

• Age: 20 Years - 90 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

patients at high cardiovascular risk, including hypertension, hyperlipidemia, and type 2 diabetes, and arrhythmia or coronary artery disease.

You may qualify if:

• People at high cardiovascular risk.
• Clinical diagnosis of hypertension
• Clinical diagnosis of hyperlipidemia
• Clinical diagnosis of type 2 diabetes
• Clinical diagnosis of arrhythmia
• Clinical diagnosis of coronary artery disease
• Patients at the cardiology clinic.

You may not qualify if:

• People who have been diagnosed by a doctor as unsuitable for vaccination.
• People with serious injuries or catastrophic illness, such as cancer patients.
• People who stay in bed for a long time and cannot take care of themselves.

Sponsors & Collaborators

• National Taiwan University Hospital: lead

Study Sites (1)

National Taiwan University Hospital

Taipei, Chung-Shan, 10002, Taiwan

RECRUITING

MeSH Terms

Conditions

Pain; Fatigue; Headache; Myalgia; Chills; Arthralgia; Fever

Condition Hierarchy (Ancestors)

Neurologic Manifestations; Signs and Symptoms; Pathological Conditions, Signs and Symptoms; Muscular Diseases; Musculoskeletal Diseases; Neuromuscular Diseases; Nervous System Diseases; Musculoskeletal Pain; Joint Diseases; Body Temperature Changes

Study Officials

• TA-CHEN SU, Doctor

  National Taiwan University Hospital

  STUDY CHAIR

Central Study Contacts

TA-CHEN SU, Doctor

CONTACT

886-2-2312-3456; lab.of.su@gmail.com

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: September 1, 2021
• First Posted: September 5, 2021
• Study Start: September 10, 2021
• Primary Completion: December 29, 2022
• Study Completion: December 29, 2022
• Last Updated: September 16, 2021

Record last verified: 2021-09

Locations

TW (1)